News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synta Pharmaceuticals Announces Ganetespib Presentations at the Annual Meeting of the American Society of Clinical Oncology


6/4/2012 10:35:48 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced results from studies evaluating the Company’s lead drug candidate, ganetespib, a potent second-generation Hsp90 inhibitor, presented at the annual meeting of the American Society for Clinical Oncology (ASCO).

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES